The researchers examined the incidence rates, risk factors, and outcomes for IL-1 and IL-6 inhibitors in patients with systemic and non-systemic juvenile idiopathic arthritis.
Researchers compared if early initiation of disease modifying antirheumatic drugs for the treatment of psoriatic arthritis was superior to later initiation of therapy after diagnosis in a recent study...
Researchers examined the treatment patterns in patients with adult Still disease in clinical practice and assessed changes in oral glucocorticoid dose after tocilizumab administration.
To better understand aspects of adult onset Still disease, a rare disorder with complications that may be fatal, researchers examined the various clinical presentations and outcomes associated with the...
In a recent study presented at ACR Convergence 2022, researchers compared the rates of improvement and associated outcomes of upadacitinib with adalimumab for the treatment of individuals with psoriatic...
In a recent study, researchers examined the relationship between age of onset of psoriatic arthritis with clinical characteristics, prognosis, and burden of disease.
As part of the ongoing FOREMOST study, researchers examined the disease burden, disease phenotype, and the extent of joint involvement in patients with early oligoarticular psoriatic arthritis.
While early diagnosis of psoriatic arthritis is key, a new study that was released during ACR Convergence shows that there is often a delay in diagnosis. Find out which patients are at the highest risk for...
Patients with rheumatoid arthritis recently completed a survey about their experiences and satisfaction with their rheumatologist. The survey’s results were released during ACR Convergence.
